An international consortium, led by IRB Barcelona and the biotechnology company Merus, reports the discovery of MCLA-158, the first clinical candidate screened in organoids targeting cancer stem cells of solid tumors
Barcelona, 25 April 2022- Scientists from an international consortium led by Dr. Eduard Batlle, head of the Colorectal Cancer laboratory at IRB Barcelona, ICREA researcher...